Breaking News

Atara Biotherapeutics Opens New Site

Will support robust off-the-shelf T-cell immunotherapy pipeline

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Atara Biotherapeutics has opened its Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, CA. ATOM features approximately 90,000 square feet dedicated to manufacturing the company’s off-the-shelf T-cell immunotherapies, as well as additional space for R&D labs and offices for Atara’s Southern California technical operations. The facility provides production capacity to support Atara’s pipeline, and its flexible design allows for potential manufacturin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters